The global pharmaceutical coating equipment market is set to witness significant expansion over the coming years, propelled by rising demand for high-performance drug delivery systems, regulatory compliance, and the need for enhanced drug stability and efficacy. According to recent market data, the pharmaceutical coating equipment market was valued at USD 924.96 million in 2024 and is projected to reach USD 1407.64 million by 2032, growing at a CAGR of 5.44% during the forecast period from 2025 to 2032.
The U.S. Pharmaceutical Coating Equipment Market is also demonstrating notable growth, with the market size expected to rise from USD 277.94 million in 2024 to USD 399.48 million by 2032, reflecting a CAGR of 4.69% over the same period. The pharmaceutical coating equipment market is experiencing a shift towards more sophisticated systems that ensure uniformity, improved bioavailability, and protective barriers for active pharmaceutical ingredients (APIs). Technological advancements in coating processes such as aqueous-based, solvent-based, and enteric coatings are also reshaping the manufacturing landscape.
Key Market Drivers:
- Increased Demand for Modified Release Dosage Forms:
Pharmaceutical companies are increasingly adopting coating technologies to achieve controlled, delayed, or targeted drug release, thereby improving therapeutic outcomes and patient compliance.
- Regulatory Push for Quality and Compliance:
Stringent global regulations from authorities like the FDA and EMA are driving the adoption of equipment that meets Good Manufacturing Practices (GMP) and ensures product integrity, consistency, and safety.
- Rising Investments in Pharmaceutical Manufacturing:
Both established and emerging economies are expanding pharmaceutical production capabilities. This includes large-scale investments in drug manufacturing infrastructure, further boosting the demand for advanced coating systems.
- Innovation in Coating Materials and Techniques:
Emerging trends such as solvent-free coating, continuous processing, and use of novel polymers are leading to increased equipment upgrades and demand for customized coating solutions.
- Expansion of Generic and OTC Drug Markets:
The growing demand for cost-effective generic drugs and over-the-counter medications is encouraging pharmaceutical companies to enhance production lines with efficient and scalable coating systems.
Key Players
- Ohara Technologies
- ACG
- Glatt GmbH
- Romaco Group
- Thomas Processing LLC
- GEA Group Aktiengesellschaft
- Syntegon Technology GmbH
- B. Bohle Maschinen und Verfahren GmbH
- DIOSNA (LINXIS Group)
- GEBRÜDER LÖDIGE MASCHINENBAU GMBH
Conclusion:
The pharmaceutical coating equipment market is entering a dynamic phase of growth, supported by evolving drug formulations, regulatory frameworks, and the push for greater manufacturing efficiency. As the industry moves toward precision, automation, and compliance, manufacturers offering versatile and technologically advanced coating equipment will be well-positioned to capture significant market share in this rapidly expanding global market.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Related Reports
Heat Pump Water Heater U.S. Market
U.S. Geothermal Heat Pump Market
Medical Injection Molding Machine Market in U.S.
Locked
